Abstract
Angiotensin type-1 receptors (AT1 receptors) mediate various physiological actions of angiotensin (Ang II) via multiple-signal transduction pathways (1). In addition to the phospholipase C pathway and dihydropyridine-sensitive voltage-dependent calcium channels, AT1 receptors can couple to inhibition of adenylate cyclase via the guanine nucleotide binding protein Gi. Beside acting directly through Gi, AT1 receptors can modulate levels of cyclic AMP (cAMP) indirectly through receptor crosstalk. cAMP is a major second messenger of many G protein coupled receptors. One group of receptors (e.g., (3-adreno-receptors, A2 adenosine, D1 dopamine, H2 histamine, and some prostanoid receptors) elevate cAMP by activating adenylate cyclase through Gs, whereas a second group (a2 adrenoreceptors, A1 adenosine, D2 dopamine, 5HT1 metabotropic glutamate, and i opioid receptors) reduce cAMP levels by inhibiting adenylate cyclase via Gi. Accumulating evidence indicates that signaling crosstalk can occur between AT receptors and receptors for atrial natriuretic factor (ANF) (2), bradykinin (3), catecholamines (4), adrenocorticotropin releasing hormone (5), vasopressin (6), and dopamine (7). Ang II is also found to indirectly modulate cyclic GMP (cGMP) levels via nitric oxide (8,9).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ohnishi, J., Ishido, M., Shibata, T., Inagami, T., Murakami, K., and Miyazaki, H. (1992) The rat angiotensin II AT1A receptor couples with three different signal transduction pathways. Biochem. Biophys. Res. Commun. 186, 1094ā1101.
Palaparti, A. and Anand-Srivastava, M. B. (1998) Angiotensin II modulates ANP-R2/ANP-C receptor-mediated inhibition of adenylyl cyclase in vascular smooth muscle cells: role of protein kinase C. J. Mol. Cell. Cardiol. 30, 1471ā1482.
Siragy, H. M. and Carey, R. M. (1999) Protective role of the angiotensin AT2 receptor in a renal wrap hypertension model. Hypertension 33, 1237ā1242.
Inoue, T., Mi, Z., Gillespie, D. G., Dubey, R. K., and Jackson, E. K. (1999) Angiotensin receptor subtype 1 mediates angiotensin II enhancement of isoprot-erenol-induced cyclic AMP production in preglomerular microvascular smooth muscle cells. J. Pharmacol. Exp. Ther. 288, 1229ā1234.
Richard, D. E., Laporte, S. A., Bernier, S. G., Leduc, R., and Guillemette, G. (1997) Desensitization of AT1 receptor-mediated cellular responses requires long term receptor down-regulation in bovine adrenal glomerulosa cells. Endocrinology 138, 3828ā3835.
Klingler, C., Ancellin, N., Barrault, M. B., Morel, A., Buhler, J. M., Elalouf, J. M., et al. (1998) Angiotensin II potentiates vasopressin-dependent cAMP accumulation in CHO transfected cells. Mechanisms of cross-talk between AT1A and V2 receptors. Cell. Signal. 10, 65ā74.
Hussain, T., Abdul-Wahab, R., Kotak, D. K., and Lokhandwala, M. F. (1998) Bromocriptine regulates angiotensin II response on sodium pump in proximal tubules. Hypertension 32, 1054ā1059.
Pollman, M. J., Yamada, T., Horiuchi, M., and Gibbons, G. H. (1996) Vasoactive substances regulate vascular smooth muscle cell apoptosis. Countervailing influences of nitric oxide and angiotensin II. Circ. Res. 79, 748ā756.
Matsubara, H. (1998) Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases. Circ. Res. 83, 1182ā1191.
Hopwood, N. D. and Gurdon, J. B. (1990) Activation of muscle genes without myogenesis by ectopic expression of MyoD in frog embryo cells. Nature 347, 197ā200.
Seidman, S., Aziz-Aloya, R. B., Timberg, R., Loewenstein, Y., Velan, B., Shafferman, A., et al. (1994) Overexpressed monomeric human acetylcholinest-erase induces subtle ultrastructural modifications in developing neuromuscular junctions of Xenopus laevis embryos. J. Neurochem. 62, 1670ā1681.
Sandberg, K., Bor, M., Ji, H., Markwick, A. J., Millan, M. A., and Catt, K. J. (1990) Angiotensin II-induced calcium mobilization in oocytes by signal transfer through gap junctions. Science 249, 298ā301.
Ji, H., Sandberg, K., and Catt, K. J. (1991) Novel angiotensin II antagonists distinguish amphibian from mammalian angiotensin II receptors expressed in Xenopus laevis oocytes. Mol. Pharmacol. 39, 120ā123.
Ji, H., Sandberg, K., Bonner, T. I., Catt, K. J. (1993) Differential activation of inositol 1,4,5-trisphosphate-sensitive calcium pools by muscarinic receptors in Xenopus laevis oocytes. Cell Calcium 14, 663ā676.
Sandberg, K., Markwick, A. J., Trinh, D. P., and Catt, K. J. (1988) Calcium mobilization by angiotensin II and neurotransmitter receptors expressed in Xenopus laevis oocytes. FEBS Lett. 241, 177ā180.
Sandberg, K., Ji, H., Clark, A. J., Shapira, H., and Catt, K. (1992) Cloning and expression of a novel rat angiotensin II receptor subtype. J. Biol. Chem. 267, 9455ā9458.
Sandberg, K., Bor, M., Ji, H., Carvallo, P. M., and Catt, K. J. (1993) Atrial natri-uretic factor activates cyclic adenosine 3ā,5ā-monophosphate phosphodiesterase in Xenopus laevis oocytes and potentiates progesterone-induced maturation via cyclic guanosine 5ā-monophosphate accumulation. Biol. Reprod. 49, 1074ā1082.
Seidman, S. and Soreq, H. (1997) Transgenic Xenopus. Humana, Totowa, NJ, p. 28.
Cheng, H. S., So, S. C., Law, S. H., and Chan, H. C. (1999) Angiotensin II-medi-ated signal transduction events in cystic fibrosis pancreatic duct cells. Biochim. Biophys. Acta 1449, 254ā260.
Dumont, J. N. (1972) Oogenesis in Xenopus laevis (Daudin). I stages of oocytes development in laboratory maintained animals. J. Morphol. 136, 153ā180.
Miller, J. L. (1983) Use of microinjection techniques to study protein kinase and protein phosphorylation in amphibian oocytes. Methods Enzymol. 99, 219ā226.
Horton, J. K. and Baxendale, P. M. (1995) Mass measurements of cyclic AMP formation by radioimmunoassay, enzyme immunoassay, and scintillation proximity assay. Methods Mol. Biol. 41, 91ā105.
Patel, A. and Linden, J. (1988) Purification of 125I-labeled succinyl cyclic nucle-otide tyrosine methyl esters by high-performance liquid chromatography. Anal. Biochem. 168, 417ā420.
Wu, M. and Gerhart, J. (1991) Raising Xenopus in the laboratory. Methods Cell Biol. 36, 3ā18.
Dascal, N. (1987) The use of Xenopus oocytes for the study of ion channels. CRC Crit. Rev. Biochem. 22, 317ā387.
Smith, L. D., Xu, W. L., and Varnold, R. L. (1991) Oogenesis and oocyte isolation. Methods Cell Biol. 36, 45ā60.
Steiner, A. L., Parker, C. W., and Pipnis, D. M. (1972) Radioimmunoasay for cyclic nucleotides. J. Biol. Chem. 247, 1106ā1113.
Harper, J. F. and Brooker, G. (1975) Femtomole sensitive radioimmunoassay for cyclic AMP and cyclic GMP after 2ā0 acetylation by acetic anhydride in aqueous solution.J. Cyclic NucleotideRes. 1, 207ā218.
Daniels, C. K., Zhang, L., Musser, B., and Vestal, R. E. (1994) A solid-phase radioimmunoassay for cyclic AMP. J. Pharmacol. Toxicol. Methods 31, 41ā46.
Berg, W. and Hornbeck, P. V. (1993) A micro-radioimmunoassay for the measurement of intracellular cAMP. Biotechniques 15, 56ā59.
Bauer, P. H., Chiu, A. T., and Garrison, J. C. (1991) DuP 753 can antagonize the effects of angiotensin II in rat liver. Mol. Pharmacol. 39, 579ā585.
Woodcock, E. A. and Johnston, C. I. (1984) Inhibition of adenylate cyclase in rat adrenal glomerulosa cells by angiotensin II. Endocrinology 115, 337ā341.
Marie, J. and Jard, S. (1983) Angiotensin II inhibits adenylate cyclase from adrenal cortex glomerulosa zone. FEBS Lett. 159, 97ā101.
Everett, A. D., Heller, F., and Fisher, A. (1996) AT1 receptor gene regulation in cardiac myocytes and fibroblasts. J. Mol. Cell. Cardiol. 28, 1727ā1736.
Ganguly, A., Chiou, S., West, L. A., and Davis, J. S. (1989) Atrial natriuretic factor inhibits angiotensin-induced aldosterone secretion: not through cGMP or interference with phospholipase C. Biochem. Biophys. Res. Commun. 159, 148ā154.
Thekkumkara, T. J., Thomas, W. G., Motel, T. J., and Baker, K. M. (1998) Functional role for the angiotensin II receptor (AT1A) 3ā-untranslated region in determining cellular responses to agonist: evidence for recognition by RNA binding proteins. Biochem. J. 329, 255ā264.
Conchon, S., Barrault, M. B., Miserey, S., Corvol, P., and Clauser, E. (1997) The C-terminal third intracellular loop of the rat AT1A angiotensin receptor plays a key role in G protein coupling specificity and transduction of the mitogenic signal. J. Biol. Chem. 272, 25,566ā25,572.
Wang, X., Nickenig, G., and Murphy, T. J. (1997) The vascular smooth muscle type I angiotensin II receptor mRNA is destabilized by cyclic AMP-elevating agents. Mol. Pharmacol. 52, 781ā787.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Ā© 2001 Humana Press Inc.
About this protocol
Cite this protocol
Ji, H. (2001). Measurement of Cyclic AMP and Cyclic GMP in Xenopus Oocytes Stimulated with Angiotensin II and Atrial Natriuretic Factor. In: Wang, D.H. (eds) Angiotensin Protocols. Methods in Molecular Medicineā¢, vol 51. Humana Press. https://doi.org/10.1385/1-59259-087-X:363
Download citation
DOI: https://doi.org/10.1385/1-59259-087-X:363
Publisher Name: Humana Press
Print ISBN: 978-0-89603-763-2
Online ISBN: 978-1-59259-087-2
eBook Packages: Springer Protocols